Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization.
Pharmaceutics
; 15(9)2023 Sep 20.
Article
in En
| MEDLINE
| ID: mdl-37765321
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmaceutics
Year:
2023
Document type:
Article
Affiliation country:
New Zealand
Country of publication:
Switzerland